Marathon Pharmaceutical Drops Out Of PhRMA Following Drug Price Controversy
Marathon Pharmaceuticals, LLC | April 24, 2017
With the sale of its controversial rare-disease drug finalized, Marathon Pharmaceuticals has taken the unusual step of resigning from the powerful industry lobbying group PhRMA.